Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. - Wikidata - wikimedia - TriplyDB

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

http://www.wikidata.org/entity/Q38385402

about

Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review The expanding landscape of diffusion-weighted MRI in prostate cancer Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.Implementation of Multi-parametric Prostate MRI in Clinical Practice.Role of MRI in the diagnosis and management of prostate cancer.Is contrast enhancement needed for diagnostic prostate MRI?Prostate cancer risk stratification with magnetic resonance imaging.Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.Multiparametric MRI of the prostate gland: technical aspects.Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.DCE MRI of prostate cancer.Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.Multi-parametric MRI imaging of the prostate-implications for focal therapy.(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.The limitations of multiparametric magnetic resonance imaging also must be borne in mind.MRI/US fusion-guided biopsy: performing exclusively targeted biopsies for the early detection of prostate cancer.Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.Role of multi-parametric MRI of the prostate for screening and staging: Experience with over 1500 cases.MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.

P2860

Q26749212-98DEE3E9-54A2-41F0-9F42-2E67E4234A90 Q31121589-56E86EB3-0A0D-4416-AB52-D9A9EE580327 Q33762501-9E3A8ED3-B939-4A9C-A488-254FC41859EC Q33783620-FE96E30D-4A19-41F9-A9F9-F5734610FF34 Q36100707-27359B86-65E0-44A2-BD5E-04FFD2470A92 Q38528397-41E7124D-2565-4407-995C-4682A728F9E5 Q38586444-8FF29AA0-1823-4EBE-8B14-913EA7B12464 Q38671168-D0E53B79-973F-42A0-895B-26E22C8CBECC Q38796980-8BBB52D2-CBA6-4908-96B9-62F4EC92A24B Q38829439-25B4561D-DA3D-4841-8B38-5638876DDB9A Q38830576-7796362A-B838-4755-B8F5-B3DC2C4B7308 Q38837797-220BA4E1-E084-4828-AB01-1512D3941090 Q38837802-51E34917-FB18-4BA8-A5BC-BDCC0A6C2A06 Q38959728-EAAAF256-B9D4-4320-A125-2D939E283D31 Q39446420-01D05470-08FA-4236-934A-8766594E73DC Q39572115-F0D06E02-8A73-41C1-A957-0FC4F3B606D8 Q40678297-D73251E7-33A5-4F52-A0C6-DF14E7C325A9 Q50093849-732F9057-B150-44AA-801A-3651F8EB89B6 Q51731968-0790BBEE-7153-4881-96E7-0D75BF0F217F Q52741581-F948852A-EF0A-4241-A45E-6D0FE1A470BC Q52988044-0A31041F-5306-4D23-BB8E-7DA913B8ED57

P2860

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

http://www.wikidata.org/entity/Q38385402

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

@en

type

label

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

@en

prefLabel

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

@en

P1433

Q38385402-AC93A468-8F3B-4273-87E5-010E9B0D55FD

P1476

Q38385402-27B17E5A-CFFE-4EC0-9ABC-34D5BBD31298

P2093

Q38385402-2305613A-5AE5-470D-9A97-6529D84937C1

Q38385402-CB0C8E10-AA74-49B8-BB93-47CA289FB9C4

Q38385402-FBFE27B0-8102-47F9-9D51-9F12FECE25E6

P2860

Q38385402-057F6B2E-80A6-4490-ACE0-B9AD504E0180

Q38385402-07ABED5E-AD98-45AF-BDE2-35115A2ED966

Q38385402-09016BF7-1DC5-483D-81E5-BBDCBF4CD5E2

Q38385402-1B0A2DEC-F1B9-4DA0-B670-22736656AF49

Q38385402-26F28F34-8144-4325-AF30-A181542B8FC0

Q38385402-2FD5FA2F-5850-4190-BC42-82492E501D2D

Q38385402-389E4971-C34E-4B2D-A123-6FB25786B9BB

Q38385402-4BCB0A7D-A77A-4C76-A3EA-27BF8BCC3DE2

Q38385402-5952027C-66EB-4C21-9F66-3FC0EF26D4EF

Q38385402-5C305936-6509-4E12-A091-8426251AB407

P304

Q38385402-54FD1F13-3EFD-4C52-A2E8-E4AF20F8E8F6

P31

Q38385402-4f72e8a8-1aa0-4203-933f-16bb011e8fc8

Q38385402-F7FE85A2-674C-489A-B2DB-18C48F28F689

P356

Q38385402-24693654-CDC8-4CCE-8B96-B262B7C17DBB

P407

Q38385402-997EA33C-8A98-446A-8A45-1FE2C00D6E20

P433

Q38385402-EC06F152-E95E-45DD-A678-624D6643AA99

P478

Q38385402-7BCCC199-C324-486D-85BA-DC8B09950EAB

P50

Q38385402-C867D860-4882-4369-BD9B-AC9F91FD3A8C

P577

Q38385402-BAF19B6F-83D7-4537-8B9A-5036DF3936D3

P698

Q38385402-87846C4C-EC1F-461A-9E18-35D478BD6FEE

P932

Q38385402-3893A74D-53E1-4ACE-8ABA-2EB968301342

P356

P1433

American Journal of Roentgenology

P1476

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis

@en

P2093

Brian Paul Hobbs

http://www.w3.org/2001/XMLSchema#string

Cher Heng Tan

http://www.w3.org/2001/XMLSchema#string

Vikas Kundra

http://www.w3.org/2001/XMLSchema#string

P2860

Advancements in MR imaging of the prostate: from diagnosis to interventions

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

The MRI measurement of NMR and physiological parameters in tissue to study disease process.

Prostate cancer: 1.5 T endo-coil dynamic contrast-enhanced MRI and MR spectroscopy--correlation with prostate biopsy and prostatectomy histopathological data.

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change.

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.

Angiogenesis imaging in the management of prostate cancer.

Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer.

P304

W439-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2214/AJR.14.13373

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25794093

http://www.w3.org/2001/XMLSchema#string

P932

5152763

http://www.w3.org/2001/XMLSchema#string